Market Overview

Benchmark Initiates Applied DNA Sciences With Speculative Buy

Related APDN
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
58 Biggest Movers From Yesterday

Analysts at Benchmark initiated coverage on Applied DNA Sciences Inc (NASDAQ: APDN) with a Speculative Buy rating.

The target price for Applied DNA Sciences is set to $5.

Applied DNA Sciences shares have dropped 61.36 percent over the past 52 weeks, while the S&P 500 index has surged 11.87 percent in the same period.

Applied DNA Sciences' shares rose 2.41 percent to close at $2.55 on Friday.

Latest Ratings for APDN

Aug 2018Maxim GroupMaintainsBuyBuy
Apr 2018Maxim GroupAssumesBuy
May 2015BenchmarkInitiates Coverage onSell

View More Analyst Ratings for APDN
View the Latest Analyst Ratings

Posted-In: BenchmarkInitiation Analyst Ratings


Related Articles (APDN)

View Comments and Join the Discussion!

Latest Ratings

SSTIImperial CapitalDowngrades49.0
OSPNImperial CapitalDowngrades20.0
ENBLStifel NicolausUpgrades17.0
FAROGabelli & Co.Upgrades0.0
BDCLongbow ResearchDowngrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Wedbush Initiates Blueprint Medicines With Outperform

Bradesco Corretora Initiates Copa Holdings At Outperform